Bessemer Group’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.84M Buy
46,019
+220
+0.5% +$18.1K 0.01% 656
2026
Q2
$3.04M Sell
45,799
-22
-0% -$1.86K ﹤0.01% 760
2026
Q1
$4.56M Buy
45,821
+12,812
+39% +$1.67M 0.01% 513
2025
Q4
$4.02M Buy
33,009
+32,766
+13,484% +$4.11M 0.01% 478
2025
Q3
$27K Buy
243
+70
+40% +$8.19K ﹤0.01% 1608
2025
Q2
$23K Buy
173
+16
+10% +$1.76K ﹤0.01% 1539
2025
Q1
$11K Buy
157
+104
+196% +$7.15K ﹤0.01% 1746
2024
Q4
$3K Buy
53
+23
+77% +$2.14K ﹤0.01% 2162
2024
Q3
$5K Buy
+30
New +$4.62K ﹤0.01% 1953
2021
Q1
– Sell
-1,400
Closed -$28K – 1638
2020
Q4
$28K Sell
1,400
-400
-22% -$5.92K ﹤0.01% 1116
2020
Q3
$25K Sell
1,800
-900
-33% -$15.4K ﹤0.01% 1025
2020
Q2
$48K Buy
+2,700
New +$42.2K ﹤0.01% 1349

Other funds holding TMDX

Bessemer Group's TMDX Position: Q3 2026 in Review

Bessemer Group increased its Transmedics (TMDX) stake by 0.48% in Q3 2026, buying an estimated $18.1K and bringing the position to 46,019 shares worth $3.84M. The position accounts for 0.01% of the portfolio, ranked #656.

Bessemer Group first reported a position in TMDX in Q2 2020 and has held it in 12 quarters since. The position peaked at $4.56M in Q1 2026. 385 funds tracked by Wall St. Rank hold TMDX as of Q3 2026.

  • Bessemer Group held 46,019 shares of Transmedics worth $3.84M as of Q3 2026.
  • Bessemer Group bought 220 Transmedics shares in Q3 2026, an estimated $18.1K.
  • Transmedics made up 0.01% of Bessemer Group's portfolio in Q3 2026, its #656 holding.
  • Bessemer Group first reported a position in Transmedics in Q2 2020 and has held it in 12 quarters since.
  • Bessemer Group's Transmedics position peaked at $4.56M in Q1 2026.
  • 385 funds tracked by Wall St. Rank held Transmedics as of Q3 2026.

Based on Bessemer Group's 13F filing for Q3 2026, filed 9 Nov 2026.